Kun Meng
Directeur Général chez Beijing Shenogen Pharma Group Ltd.
Postes actifs de Kun Meng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur Général | - | - |
| Président | - | - | |
| Fondateur | - | - |
Historique de carrière de Kun Meng
Formation de Kun Meng
| University of Chinese Academy of Sciences | Doctorate Degree |
| Harvard University | Graduate Degree |
Statistiques
Internationale
| Chine | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
